Natural Product: NPC485618

Natural Product IDNPC485618
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
NREGVTHCHKOXLC-VXLWULRPSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 10835998
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0000337] Flavans
          • [CHEMONTID:0003642] 8-prenylated flavans
            • [CHEMONTID:0003508] 8-prenylated flavanones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey NREGVTHCHKOXLC-VXLWULRPSA-N
Standard InCHI InChI=1S/C26H30O5/c1-15(2)10-11-17(16(3)4)12-19-21(28)13-24(30-5)25-22(29)14-23(31-26(19)25)18-8-6-7-9-20(18)27/h6-10,13,17,23,27-28H,3,11-12,14H2,1-2,4-5H3/t17?,23-/m0/s1
SMILES CC(=CCC(Cc1c(cc(c2C(=O)C[C@@H](c3ccccc3O)Oc12)OC)O)C(=C)C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   422.21 Volume:   452.806
?
Van der Waals volume.
Dense:   0.932 LogP:   4.769
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.861
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.031
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   20.0
TPSA:   75.99
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   2.0 Rings:   3.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.543 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.795 Fsp3:   0.346
MCE-18:   65.4
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.898 Fluc inhibitor:   0.576
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.396
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.588
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.249 Promiscuous compounds:   0.04

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.81 MDCK Permeability:   -4.552
Pgp-inhibitor:   0.702 Pgp-substrate:   0.001
PAMPA:   0.005
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.007 30% Bioavailability (F30%):   0.055
50% Bioavailability (F50%):   0.903

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.215 MRP1:   0.962
Plasma Protein Binding (PPB):   96.328% Volume Distribution (VD):   0.182
Fu: 2.982%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.955
OATP1B3 inhibitor:   0.987 BCRP inhibitor:   0.674
BSEP inhibitor:   0.994

ADMET: Metabolism

CYP1A2-inhibitor:   0.058 CYP1A2-substrate:   0.913
CYP2C19-inhibitor:   0.988 CYP2C19-substrate:   0.379
CYP2C9-inhibitor:   0.547 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.038 CYP2D6-substrate:   0.931
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.533
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.064
HLM stability:   0.942
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.811 Half-life (T1/2):  0.848

ADMET: Toxicity

hERG Blockers:  0.081 hERG Blockers (10um):  0.497
Human Hepatotoxicity (H-HT):  0.847 Drug-induced Liver Injury (DILI):  0.47
AMES Toxicity:  0.441 Rat Oral Acute Toxicity:  0.813
Maximum Recommended Daily Dose:  0.702 Skin Sensitization:  0.955
Carcinogencity:  0.264 Eye Corrosion:  0.001
Eye Irritation:  0.824 Respiratory Toxicity:  0.9
Drug-induced Neurotoxicity:  0.902 Ototoxicity:  0.738
Hematotoxicity:  0.191 Drug-induced Nephrotoxicity:  0.791
Genotoxicity:  0.933 RPMI-8226 Immunitoxicity:  0.091
A549 Cytotoxicity:  0.627 Hek293 Cytotoxicity:  0.317
BCF:   1.955
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.926
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.887
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.277
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[10654410]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. root n.a. PMID[10843587]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota Roots n.a. n.a. PMID[15568770]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. root n.a. PMID[16392664]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. root n.a. PMID[16933887]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota roots Hualien Hsien, Taiwan 2003-JUL PMID[16933887]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. root n.a. PMID[17951038]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[18175961]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[24295087]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[27575476]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota Roots n.a. n.a. PMID[30298740]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota Roots n.a. n.a. PMID[9868163]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. root n.a. Database[Article]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO19231 Sophora flavescens Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 2.5 ug.mL-1 PMID[10654410]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 5.0 ug.mL-1 PMID[10654410]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 5.0 ug.mL-1 PMID[10654410]
NPT167 Organism Propionibacterium acnes Propionibacterium acnes MIC = 10.0 ug.mL-1 PMID[10654410]
NPT2 Others Unspecified n.a. Inhibition = 4.1 % PMID[10654410]
NPT2 Others Unspecified n.a. Inhibition = 23.6 % PMID[10654410]
NPT2 Others Unspecified n.a. Inhibition = 73.5 % PMID[10654410]
NPT2 Others Unspecified n.a. Activity = 27.3 % PMID[10654410]
NPT2 Others Unspecified n.a. Activity = 67.5 % PMID[10654410]
NPT2 Others Unspecified n.a. Activity = 82.4 % PMID[10654410]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC485618 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8333 Intermediate Similarity NPC77794
0.8333 Intermediate Similarity NPC225660
0.8308 Intermediate Similarity NPC473014
0.791 Intermediate Similarity NPC485619
0.7681 Intermediate Similarity NPC235217
0.7681 Intermediate Similarity NPC485611
0.7206 Intermediate Similarity NPC81697
0.7206 Intermediate Similarity NPC485615
0.6486 Remote Similarity NPC485614
0.6486 Remote Similarity NPC127059
0.6164 Remote Similarity NPC125894
0.6104 Remote Similarity NPC485616
0.6104 Remote Similarity NPC217149
0.6053 Remote Similarity NPC473013
0.6027 Remote Similarity NPC278249
0.6027 Remote Similarity NPC473015
0.6027 Remote Similarity NPC223812
0.5974 Remote Similarity NPC107177
0.5974 Remote Similarity NPC485612
0.589 Remote Similarity NPC85162
0.5694 Remote Similarity NPC76338
0.5694 Remote Similarity NPC250242
0.5526 Remote Similarity NPC131568
0.5068 Remote Similarity NPC306829

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC485618 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data